Coloplast | COLOB - Cash And Equivalent


Coloplast reported 911M in Cash and Equivalent for its fiscal quarter ending in September of 2023.





Cash And Equivalent Change Date
Ambu A/S DKK 735M 16M Dec/2025
Avanos Medical USD 89.8M 19.3M Dec/2025
Brookdale Senior Living USD 279.12M 25.67M Dec/2025
Cencora USD 1.75B 2.6B Dec/2025
Coloplast 911M 497M Sep/2023
Computer Programs Systems USD 24.85M 4.93M Dec/2025
Encompass Health USD 72.2M 23.5M Dec/2025
Enovis USD 36.39M 2.77M Dec/2025
GE HealthCare Technologies USD 4.49B 487M Dec/2025
OPKO Health USD 369.1M 42.87M Dec/2025
Pediatrix Medical Group USD 375.24M 35.18M Dec/2025
Veradigm USD 492.6M 7.57M Sep/2022
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025